Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.

× No keyword cloud information.

142 in total

1. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Authors: E J Wallis; L E Ramsay; I Ul Haq; P Ghahramani; P R Jackson; K Rowland-Yeo; W W Yeo
Journal: BMJ Date: 2000-03-11

2. Diabetes care needs evidence based interventions to reduce risk of vascular disease.

Authors: C D Byrne; S H Wild
Journal: BMJ Date: 2000-06-10

3. Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors:
Journal: Heart Date: 1998-12 Impact factor: 5.994

4. Long standing heart disease should be better screened.

Authors: T E Strandberg; H Vanhanen
Journal: BMJ Date: 2000-10-28

Review 5. Update in internal medicine.

Authors: F López-Jiménez; M Brito; Y W Aude; P Scheinberg; M Kaplan; D A Dixon; N Schneiderman; J F Trejo; L H López-Salazar; E J Ramírez-Barba; R Kalil; C Ortiz; J Goyos; A Buenaño; S Kottiech; G A Lamas
Journal: Arch Med Res Date: 2000 Jul-Aug Impact factor: 2.235

6. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Authors: J G Fodor; J J Frohlich; J J Genest; P R McPherson
Journal: CMAJ Date: 2000-05-16 Impact factor: 8.262

7. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study.

Authors: Juho Uusvaara; Kaisu H Pitkala; Hannu Kautiainen; Reijo S Tilvis; Timo E Strandberg
Journal: Drugs Aging Date: 2011-02-01 Impact factor: 3.923

Review 8. [Evaluation of cardiovascular risk. What table to use?].

Authors: A Maiques Galán
Journal: Aten Primaria Date: 2003-12 Impact factor: 1.137

9. A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.

Authors: Nigel Buller; David Gillen; Roman Casciano; John Doyle; Koo Wilson
Journal: Pharmacoeconomics Date: 2003 Impact factor: 4.981

10. Educational level and risk profile of cardiac patients in the EUROASPIRE II substudy.

Authors: O Mayer; J Simon; J Heidrich; D V Cokkinos; D De Bacquer
Journal: J Epidemiol Community Health Date: 2004-01 Impact factor: 3.710